Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Month, Prospective, Randomized, Multicenter, Placebo-Controlled Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Followed by a 6-Month Open-Label Extension

NCT02265393 is registered in ClinicalTrials.gov with Otonomy, Inc. as lead sponsor.

NCT NCT02265393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02265393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Month, Prospective, Randomized, Multicenter, Placebo-Controlled Safety Study of OTO-104 Given at 3-Month Intervals by Intratympanic Injection in Subjects With Unilateral Meniere's Disease Followed by a 6-Month Open-Label Extension
Lead sponsor
Otonomy, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
May 31, 2016
Enrollment
128 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

meniere's disease